Clayton et al. [12], [13] showed that exosomes released by breast-, mesotelioma and prostate cancer cell lines expressed NKG2D ligands with ability to down modulate the cognate NK cell receptor and impair the cytotoxic anti-cancer immune response. The gene discussed is KLRD1; the disease is prostate carcinoma.